Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a ...
Exploratory outcome measures include health-related quality of life, overall survival, and biomarker assessments. A broad cross-section of geographically and socioeconomically diverse clinical sites ...
(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Keynote Presentation. Dr. William Dahut discussed how ...
A clinical trial led by researchers at UT Southwestern Medical Center in Dallas could help bring an experimental treatment ...
A unique collaboration between electrical engineers and ophthalmologists solves clinical, computational challenges.
Clinical trials have been pivotal to the improvements in public health and clinical care, leading to many millions of ...
Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...
Up to 50 transplant patients will receive a genetically modified pig kidney in a clinical trial that will launch this summer ...
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of cuts to NIH funding that supports vital biomedical ...
Excessive waiting for appointments, for treatments to begin and for phone calls to be returned; a lack of coordination among ...
Clinical trial complexity, logistical challenges associated with treatments, and resource constraints at trial sites cited as top factors that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results